pembrolizumab
merck
['friends', 'congrat', 'hncsm', 'kn-412', 'pembro']
kn-412 results at #esmo22 no benefit of adjuvant pembrolizumab after chemoradiation for locally advanced head &amp; neck cancer. unfortunately negative study but congrats to all co-authors incl my friends maybe benefit in cps 20+ (post hoc) #hncsm #radonc 
Full Prof Radiation Oncology @gustaveroussy @UnivParisSaclay. EiC https://t.co/ZZv4fFrcCi. Director @SciencesCancer. Adjunct Assoc Prof @MDAndersonNews.